4.5 Article

Evaluating tumor cell- and T cell-derived extracellular vesicles as potential biomarkers of cancer and immune cell competence

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Otorhinolaryngology

Small extravesicular microRNA in head and neck squamous cell carcinoma and its potential as a liquid biopsy for early detection

Chenna R. Galiveti et al.

Summary: This study found clear differences in exo-miRNA profiles between head and neck squamous cell carcinoma (HNSCC) cells and healthy epithelial cells, with variations according to human papillomavirus (HPV) status. Additionally, differential exo-miRNA profiles were observed in serum from early-stage HNSCC cases compared to cancer-free controls.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2023)

Article Biochemistry & Molecular Biology

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

Simona Serrati et al.

Summary: This study identified circulating PD1(+) EVs as a driver of resistance to anti-PD1 therapy in metastatic melanoma patients. The analysis of single EV populations by liquid biopsy is a promising tool for stratifying patients for immunotherapy.

MOLECULAR CANCER (2022)

Article Oncology

Extracellular vesicles in anti-tumor immunity

Elisabetta Vergani et al.

Summary: The impact of extracellular vesicles (EVs) on anti-tumor immune responses is still being explored. The small size and numerous subtypes of EVs, as well as the difficulty in determining their origin, pose challenges for investigation. While the study of cancer EVs has been facilitated by the existence of tumor cell lines, understanding the phenotypes and functions of immune cell EVs in this context is more complex. The emergence of immunotherapy with immune checkpoint inhibitors has increased the need to understand the role of EVs in immune activation and response, particularly in unraveling and preventing resistance in patients.

SEMINARS IN CANCER BIOLOGY (2022)

Review Medicine, General & Internal

Combinatorial Power of cfDNA, CTCs and EVs in Oncology

Corinna Keup et al.

Summary: Liquid biopsy is a promising technique for clinical management of oncological patients, with a wide variety of analytes available for testing. Studies comparing different analytes in liquid biopsy have shown benefits of one analyte over the other, but most authors concluded that the additional analyte provides added value. However, the clinical utility of multimodal liquid biopsy testing is yet to be proven, and there is a lack of methodical standardization and mature reimbursement, logistics, and data handling.

DIAGNOSTICS (2022)

Article Cell Biology

Proteomic and Metabolomic Profiles of T Cell-Derived Exosomes Isolated from Human Plasma

Aneta Zebrowska et al.

Summary: This study demonstrates the isolation of CD3(+) exosomes from human plasma using immune capture and their subsequent molecular profiling using proteomics and metabolomics. The CD3(+) exosomes were enriched with proteins and metabolites that reflect the molecular features of T lymphocytes.
Article Biochemistry & Molecular Biology

Characteristics of Exosomes and the Vascular Landscape Regulate Exosome Sequestration by Peripheral Tissues and Brain

William A. Banks et al.

Summary: Exosomes mediate intercellular communication and their tissue sequestration levels vary among different tissues. The sequestration is regulated by both exosomes and tissues, and can be influenced by WGA and inflammation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Immunology

Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC

Diego Signorelli et al.

Summary: This study evaluated circulating EVs as potential biomarkers for ICI in NSCLC patients with low PD-L1. The results showed that higher levels of tetraspanins in R-EVs were associated with better treatment response and improved survival.

FRONTIERS IN IMMUNOLOGY (2022)

Review Oncology

Immune suppression in gliomas

Matthew M. Grabowski et al.

Summary: Gliomas evade immune detection and destruction through mechanisms such as dysfunctional T cells and NK cells, expansion of regulatory T cells and myeloid-derived suppressor cells, M2 phenotypic transformation in macrophages/microglia, upregulation of immunosuppressive factors, tumor microenvironment hypoxia, and iatrogenic effects of immunosuppressive treatments. Future research should focus on addressing these immunosuppressive mechanisms to develop treatment options with improved survival outcomes.

JOURNAL OF NEURO-ONCOLOGY (2021)

Review Biotechnology & Applied Microbiology

The potential role of tumor-derived exosomes in diagnosis, prognosis, and response to therapy in cancer

Malgorzata Czystowska-Kuzmicz et al.

Summary: Small extracellular vesicles (sEV) produced by tumors, known as TEX, act as potential cancer biomarkers by regulating the tumor microenvironment and carrying a rich cargo of membrane-bound proteins and nucleic acids. Upon transfer to recipient cells, TEX activate various molecular pathways and induce pro-tumor transcriptional changes.

EXPERT OPINION ON BIOLOGICAL THERAPY (2021)

Review Biochemistry & Molecular Biology

Exosomes as mediators of immune regulation and immunotherapy in cancer

Fernanda G. Kugeratski et al.

Summary: Exosomes play crucial roles in cancer by either promoting tumor development or inhibiting tumor immune suppression. They deliver signals that affect immune regulation of lymphoid and myeloid cell populations in tumors.

FEBS JOURNAL (2021)

Article Oncology

Changes in circulating exosome molecular profiles following surgery/(chemo)radiotherapy: early detection of response in head and neck cancer patients

M-N Theodoraki et al.

Summary: Evaluation of plasma exosomes can potentially detect early treatment failure in locally advanced HNSCC patients undergoing conventional therapy. Changes in the relative fluorescence intensity of immunoregulatory proteins on exosomes, their ability to inhibit T cells, and adenosine production during therapy suggest a potential role in monitoring treatment response and risk stratification.

BRITISH JOURNAL OF CANCER (2021)

Review Biochemistry & Molecular Biology

Small extracellular vesicle-mediated bidirectional crosstalk between neutrophils and tumor cells

Dominique S. Rubenich et al.

Summary: Neutrophils play a crucial role in tumor progression and communicate with tumor cells through small extracellular vesicles. These vesicles modulate inflammatory responses in the tumor microenvironment. Understanding the signaling balance between tumor-derived and neutrophil-derived vesicles may lead to novel approaches for controlling tumor progression in the future.

CYTOKINE & GROWTH FACTOR REVIEWS (2021)

Review Oncology

Exosome-based liquid biopsies in cancer: opportunities and challenges

W. Yu et al.

Summary: Liquid biopsy in cancer research has seen significant progress, with efforts focused on utilizing circulating tumor cells, circulating tumor DNA, and extracellular vesicles like exosomes. Exosomes, as part of the intercellular communication system, carry tumor-derived materials and can serve as stable biomarkers for early detection and monitoring of cancer.

ANNALS OF ONCOLOGY (2021)

Article Biochemical Research Methods

Enrichment of circulating tumor-derived extracellular vesicles from human plasma

Kathryn E. Yoh et al.

Summary: This study developed an automated method to enrich tumor-derived EVs from plasma using CellSearch technology, demonstrating its efficacy and reliability in detecting specific proteins like PD-L1. Detecting EpCAM+EVs in patients with non-small cell lung carcinoma and triple negative breast cancer suggests that these are tumor-derived EVs.

JOURNAL OF IMMUNOLOGICAL METHODS (2021)

Review Oncology

Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease

Everett J. Moding et al.

Summary: ctDNA MRD predicts relapse after treatment for solid tumors, potentially revolutionizing personalized adjuvant therapies. However, results can be influenced by factors such as assay type, amount of ctDNA release, and technical background, requiring cautious consideration.

CANCER DISCOVERY (2021)

Article Cell Biology

Proteomic profile of melanoma cell-derived small extracellular vesicles in patients' plasma: a potential correlate of melanoma progression

Monika Pietrowska et al.

Summary: This study demonstrates that molecular profiling of sEV isolated from plasma of cancer patients can distinguish tumor-derived sEV from non-malignant cell-derived sEV and identify potential prognostic biomarkers for melanoma.

JOURNAL OF EXTRACELLULAR VESICLES (2021)

Article Cell Biology

The Role of Tumor-Derived Exosomes (TEX) in Shaping Anti-Tumor Immune Competence

Theresa L. Whiteside

Summary: Recent studies indicate that extracellular vesicles (EVs) in the tumor microenvironment (TME) play a crucial role in promoting cancer progression by reprogramming the TME and suppressing immune responses. Specifically, tumor-derived small EVs or exosomes (TEX) carry immunosuppressive proteins and microRNAs targeting suppressive pathways, contributing to immune cell suppression and resistance to therapy. The adenosinergic pathway in TEX is identified as a significant mechanism for cancer-driven immune cell suppression and immune therapy resistance.
Review Immunology

Extracellular vesicles in immunomodulation and tumor progression

Carolyn Marar et al.

Summary: Extracellular vesicles play a crucial role in regulating the immune response during tumor progression, serving as mediators of communication between cancer and immune cells. Their diverse molecular cargo can shed light on tumor progression mechanisms, offering diagnostic and prognostic tools for immunologists.

NATURE IMMUNOLOGY (2021)

Article Oncology

Small Extracellular Vesicles in Pre-Therapy Plasma Predict Clinical Outcome in Non-Small-Cell Lung Cancer Patients

Eleni-Kyriaki Vetsika et al.

Summary: This study found that pre-therapy total sEV protein levels in plasma are associated with clinical outcomes in treatment-naive NSCLC patients, with high levels serving as significant negative predictors of PFS and OS. Additionally, there is a positive correlation between sEV TEP levels and the percentages of circulating CD8(+)PD-1(+) and CD8(+)PD-L1(+)T cells, suggesting sEV may hinder anti-tumor immune responses through the PD-L1/PD-1 pathway. Pre-therapy plasma sEV levels could potentially be used as non-invasive predictors of NSCLC progression and treatment outcomes.

CANCERS (2021)

Article Oncology

The plasma exosomal miR-1180-3p serves as a novel potential diagnostic marker for cutaneous melanoma

Yeye Guo et al.

Summary: This study revealed that decreased exosomal miR-1180-3p in plasma could serve as a promising diagnostic marker for melanoma in Asian patients. The expression level of miR-1180-3p was found to be negatively correlated with the proliferation, migration, and invasion of melanoma cells. Functional analysis identified ST3GAL4 as a potential target gene that was negatively regulated by miR-1180-3p, contributing to the malignant phenotype of melanoma cells.

CANCER CELL INTERNATIONAL (2021)

Review Biochemistry & Molecular Biology

Current Search through Liquid Biopsy of Effective Biomarkers for Early Cancer Diagnosis into the Rich Cargoes of Extracellular Vesicles

Irene Tatischeff

Summary: Regardless of the type of cancer, early diagnosis is crucial for optimal treatment outcomes. Therefore, the search for efficient, specific, and sensitive cancer biomarkers is urgently needed.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Tumor-Derived Exosomes (TEX) and Their Role in Immuno-Oncology

Theresa L. Whiteside et al.

Summary: Extracellular vesicles, especially tumor-derived exosomes, play a crucial role in cancer by mediating interactions between tumor cells and immune cells. The molecular and functional profiles of these EVs vary in cancer patients, impacting immune cell functions and disease progression. Potential biomarkers and monitors of immune competence in cancer patients can be identified through the analysis of these EVs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Immunology

Extracellular vesicle- and particle-mediated communication shapes innate and adaptive immune responses

Fanny A. Pelissier Vatter et al.

Summary: EVPs play a crucial role in immune homeostasis and pathophysiology, regulating immune responses and impacting disease progression.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Oncology

Proteomic profiles of melanoma cell-derived exosomes in plasma: discovery of potential biomarkers of melanoma progression

Sujan Kumar Mondal et al.

Summary: Liquid biopsy, including CTC, ctDNA, and TEX, emerges as a novel approach for early detection, noninvasive monitoring of responses to therapy, and predicting patient survival. TEX, which mimic tumor cells in their proteomic and genetic content, show potential as diagnostic and prognostic markers in melanoma according to recent proteomic analyses.

MELANOMA RESEARCH (2021)

Article Oncology

Small Extracellular Vesicles from Head and Neck Squamous Cell Carcinoma Cells Carry a Proteomic Signature for Tumor Hypoxia

Alicja Gluszko et al.

Summary: Tissue hypoxia is a common feature in HNSCC, leading to alterations in tumor cells. The study found that sEVs released by HNSCC cells under hypoxic conditions have a unique protein composition, which can potentially serve as biomarkers for different degrees of tissue hypoxia and as a resource for anti-angiogenic therapies.

CANCERS (2021)

Article Oncology

Plasma Exosome-Derived SENP1 May Be a Potential Prognostic Predictor for Melanoma

Hejuan Hu et al.

Summary: Plasma exosome-derived SENP1 levels were significantly elevated in melanoma patients compared to healthy controls. Higher levels of plasma exosome-derived SENP1 were associated with worse disease-free survival and overall survival in melanoma patients, suggesting a potential prognostic value for predicting the 3-year outcomes.

FRONTIERS IN ONCOLOGY (2021)

Article Cell Biology

Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients

Marine Cordonnier et al.

JOURNAL OF EXTRACELLULAR VESICLES (2020)

Article Multidisciplinary Sciences

Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells

Priyanka Sharma et al.

SCIENTIFIC REPORTS (2020)

Review Pharmacology & Pharmacy

Therapeutic Application of Small Extracellular Vesicles (sEVs): Pharmaceutical and Pharmacokinetic Challenges

Yoshinobu Takakura et al.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2020)

Review Immunology

Tumor-Derived Exosomes in Immunosuppression and Immunotherapy

Wioletta Olejarz et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2020)

Review Immunology

The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer

Yanyan Tang et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

Ayuko Hoshino et al.

Article Biochemistry & Molecular Biology

Arginase-1+Exosomes from Reprogrammed Macrophages Promote Glioblastoma Progression

Juliana H. Azambuja et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Biochemistry & Molecular Biology

Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation

William A. Banks et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Editorial Material Immunology

Circulating tumor cells: Ready for translation?

Zoi Diamantopoulou et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Review Cell Biology

Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications

Reza Rahbarghazi et al.

CELL COMMUNICATION AND SIGNALING (2019)

Review Biochemistry & Molecular Biology

The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications

Francesco Ingenito et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Oncology

Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment

Xinyu Tian et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Article Immunology

TcellSubC: An Atlas of the Subcellular Proteome of Human T Cells

Rubin Narayan Joshi et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Biotechnology & Applied Microbiology

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Jerome Galon et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Review Pharmacology & Pharmacy

Potential roles of tumor-derived exosomes in angiogenesis

Nils Ludwig et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2018)

Article Oncology

Serum exosomal microRNAs as potent circulating biomarkers for melanoma

Li Tengda et al.

MELANOMA RESEARCH (2018)

Article Immunology

Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence

M. -N. Theodoraki et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)

Article Oncology

Exosomes from HNSCC Promote Angiogenesis through Reprogramming of Endothelial Cells

Nils Ludwig et al.

MOLECULAR CANCER RESEARCH (2018)

Review Pathology

The potential of tumor-derived exosomes for noninvasive cancer monitoring: an update

Theresa L. Whiteside

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)

Article Cell Biology

Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma

Priyanka Sharma et al.

JOURNAL OF EXTRACELLULAR VESICLES (2018)

Article Oncology

Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients

Marie-Nicole Theodoraki et al.

CLINICAL CANCER RESEARCH (2018)

Article Medical Laboratory Technology

Circulating melanoma exosomes as diagnostic and prognosis biomarkers

Estibaliz Alegre et al.

CLINICA CHIMICA ACTA (2016)

Review Medicine, Research & Experimental

Exosomes and tumor-mediated immune suppression

Theresa L. Whiteside

JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Oncology

Effect of Nasopharyngeal Carcinoma-Derived Exosomes on Human Regulatory T Cells

Dhafer Mrizak et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Review Medical Laboratory Technology

The Long Journey of Cancer Biomarkers from the Bench to the Clinic

Maria P. Pavlou et al.

CLINICAL CHEMISTRY (2013)